Fenwick’s Robert Counihan, Eric Majchrzak & Erica Sutter Discuss Patent Remedies in Drug Product Launches
An article written by Fenwick’s Robert Counihan, Eric Majchrzak and Erica Sutter was featured on Bloomberg Law exploring the remedies that patentees could seek against a pharmaceutical company looking to launch a new drug product, specifically the launch of new “innovator” products as opposed to generics.
Read the full article here: Professional Perspective: Patent Holder Remedies & Drug Product Launches